This is a strong argument to further evaluate the role of BCL2A1 in RA and, in particular, a potentially overlooked role of long-term surviving IL-17A-stimulated MCL1+ BCL2A1+-activated DCs. The gene discussed is BCL2A1; the disease is rheumatoid arthritis.